The authors demonstrated an association between a high cytoplasmic expression of β-catenin and a high tumor grade (p = 0.004) and negative estrogen receptor values (p = 0.005), and the high expression of β-catenin was thus associated with an adverse disease outcome. This evidence concerns the gene ESR1 and neoplasm.